Grace Tx - רווח נקי למניה אחת בשנים עשר החודשים האחרונים GRCE

The visualization of Grace Therapeutics, Inc. (GRCE) market value on GURU.Markets demonstrates EPS dynamics, which stand at -110.20. This US biotech's operations rely on discovering new ways to mitigate neuropathic pain. Grace Therapeutics, Inc. (GRCE) is implementing substance delivery modification methods for the therapy of seizures and neuralgia to increase treatment efficacy. The continuity of scientific research is ensured by an established storage system for necessary chemical components.
Grace Tx - פילוחים אנליטיים ומדדי מפתח (GRCE)

The high margins of Grace Therapeutics, Inc. (GRCE) orphan drugs are reflected in the historical year-over-year EPS (TTM) growth trend. This indicator measures the rate of change in net income per share over a rolling year, allowing investors to instantly capture deviations in business efficiency and operational shifts without a quarterly lag to assess capital stability.